In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.

In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.

<h4>Background</h4>In vivo efficacy assessments of antimalarials are essential for ensuring effective case management. In Ethiopia, chloroquine (CQ) without primaquine is the first-line treatment for Plasmodium vivax in malarious areas, but artemether-lumefantrine (AL) is also commonly u...

Full description

Bibliographic Details
Main Authors: Jimee Hwang, Bereket Hailegiorgis Alemayehu, Richard Reithinger, Samuel Girma Tekleyohannes, Takele Teshi, Sintayehu Gebresillasie Birhanu, Leykun Demeke, David Hoos, Zenebe Melaku, Moges Kassa, Daddi Jima, Joseph L Malone, Henry Nettey, Michael Green, Amanda Poe, Sheila Akinyi, Venkatachalam Udhayakumar, S Patrick Kachur, Scott Filler
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23717423/pdf/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23717423/pdf/?tool=EBI

Similar Items